CTRI/2023/01/048881尚未招募未知
Establish URO17 as diagnostic biomarker for bladder cancer patients in Indian population - ERADICATE
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •For Cases- patients with bladder mass about to undergo TURBT as per the standard treatment protocol for presumed urothelial cancer
- •For controlsâ?? age and gender matched healthy volunteers with no personal or family history of bladder cancer. Not having any symptoms or signs suggestive of malignancy.
排除标准
- •Patients with catheter in situ.
- •Patients who are currently undergoing radiation therapy.
- •Patient with no bladder (due to surgical removal).
- •Patients unable or unwilling to provide consent.
- •Patients finally diagnosed with non urothelial bladder cancer.
研究者
相似试验
已完成
不适用
Bladder cancer detection using a non-invasive urinary biomarker URO17™ in patients with suspected bladder cancerBladder cancerMalignant neoplasm of bladderCancerISRCTN66923582Cardiff University500
招募中
不适用
Screening for the optimum urinary biomarkers indicating cartilage wear in the knee.Cartilage injuryJPRN-UMIN000033523Tokyo Medical and Dental University10
已完成
不适用
Development of a new biomarker for the detection of colorectal cancer using plasma concentrations of amino acids and metabolitesColorectal CancerJPRN-UMIN000029920Kyorin University School of Medicine The Third Department of Internal Medicine400
尚未招募
不适用
Establishment of new diagnostic Biomarker and Characterization of protective bone marrow niche in patients with multiple myelomaC90Multiple myeloma and malignant plasma cell neoplasmsDRKS00010830niversitätsklinikum Freiburg160
已完成
不适用
Clinical significance of novel urinary markers for the diagnosis, staging, and the prediction of prognosis in patients with prostate cancerProstate cancerJPRN-UMIN000001313Department of Urology, Keio University School of Medicine500